13/11/2024  21:57:29 Diferencia +15.300 Volumen Bid21:59:56 Ask21:59:56 Capitalización de mecado Dividendo A. P/E Ratio
325.200EUR +4.94% 19
Volumen de negocios: 6,119.300
325.400Volumen de oferta: 54 326.200Tamaño/ Volumen/ Formato de Ask: 54 23.59 mil millonesEUR - -

Descripción de negocio

West Pharmaceutical Services, Inc. is a leading manufacturer of packaging components and delivery systems for injectable drugs and healthcare products. Working by the side of its customers from concept to patient, West creates products that promote the efficiency, reliability and safety of the world's pharmaceutical drug supply. West is headquartered in Exton, Pennsylvania, and supports its customers from locations in North and South America, Europe, Asia and Australia.
 

Consejo de gestión & Consejo de supervisión

CEO
Eric M. Green
Consejo de gestión
Bernard J. Birkett, Annette F. Favorite, Chris Ryan, Cindy Reiss-Clark, Dr. Quintin Lai, Kimberly Banks MacKay, Silji Abraham, Kathy dePadua
Consejo de supervisión
Eric M. Green, Deborah Keller, Douglas A. Michels, Mark Buthman, Molly E. Joseph, Myla Lai-Goldman, M.D., Paolo Pucci, Robert Friel, Thomas W. Hofmann, Stephen Lockhart, William F. Feehery
 

Datos de la empresa

Nombre: West Pharmaceutical Services Inc.
Dirección: 530 Herman O. West Drive,Exton, PA 19341-0645, USA
Teléfono: +1-610-594-2900
Fax: -
E-mail: west.pharmaceutical....rma.com west.pharmaceutical.services@westpharma.com
Internet: www.westpharma.com
Industria: Healthcare
Sector: Pharmaceutical Industry
Subsector: Pharmaceuticals
Fin del año financiero: 31/12
Acciones de libre circulación: 67.50%
Fecha de OPI: -

Relación con inversores

Nombre: Dr. Quintin Lai
IR teléfono: +1-610-594-3318
IR-fax: -
IR e-mail: Quintin.Lai@westpharma.com

Accionistas mayoritarios

Otros
 
51.78%
Vanguard Group Inc
 
12.35%
BlackRock Inc.
 
10.67%
The Bank of New York Mellon Corp.
 
4.57%
State Street Corporation
 
4.49%
Price T Rowe Associates Inc Md
 
3.19%
APG Asset Management N V
 
3.15%
Franklin Resources Inc.
 
2.89%
Artisan Partners Limited Partnership
 
2.69%
Otros
 
4.22%